Nikbakht M R, Stone T W
Institute of Biomedical and Life Sciences, West Medical Building, University of Glasgow, Glasgow G12 8QQ, UK.
Eur J Pharmacol. 2001 Sep 7;427(1):13-25. doi: 10.1016/s0014-2999(01)01171-2.
The interactions between adenosine and NMDA receptors has been investigated using the paired-pulse paradigm in hippocampal slices. This technique allows the study of drug effects specifically at presynaptic terminals. The inhibitory effect of adenosine on population spikes, and the decrease of paired-pulse inhibition assessed using either population spikes or population excitatory postsynaptic potentials, were suppressed by performing the experiments in magnesium-free medium, or by superfusion of the slices with N-methyl-D-aspartate (NMDA) at a concentration (4 microM) which did not itself affect potential size. The suppressant effect of NMDA was prevented by 2-amino-5-phosphonopentanoic acid. All these interactions were still seen in the presence of bicuculline methobromide, 30 microM. Neither alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) nor kainate produced a suppression of adenosine responses. The presence of NMDA did not modify the effects of baclofen on population potentials or paired-pulse inhibition. Activating NMDA receptors by the induction of long-term potentiation or by superfusion with glycine also reduced significantly the effects of adenosine on population spikes and paired-pulse interactions. Increasing population potential size by a mechanism which did not involve the activation of NMDA receptors (increasing stimulus strength) did not change sensitivity to adenosine. When adenosine receptor-selective agonists were tested, it was found that NMDA did not modify the inhibitory effect of the adenosine A(1) receptor agonist N(6)-cyclopentyladenosine, but did enhance the excitatory effect of the adenosine A(2A) receptor agonist 2-[p-(2-carboxyethyl)phenylethylamino]-5'-N-ethylcarboxamidoadenosine (CGS21680). The combined response to NMDA and CGS21680 was prevented by the adenosine A(2A) receptor selective antagonist 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3a][1,3,5]triazin-5-ylamino]ethyl)phenol (ZM241385). It is concluded that NMDA receptor activation can suppress neuronal sensitivity to adenosine by acting at presynaptic sites, and that this interaction results from an increase in the excitatory action of adenosine A(2A) receptors, rather than a depression of A(1) receptor function.
利用海马切片中的双脉冲范式研究了腺苷与N-甲基-D-天冬氨酸(NMDA)受体之间的相互作用。该技术允许专门研究药物在突触前终末的作用。在无镁培养基中进行实验,或用浓度为4微摩尔的N-甲基-D-天冬氨酸(NMDA)对切片进行灌流(其本身不影响电位大小),可抑制腺苷对群体峰电位的抑制作用,以及使用群体峰电位或群体兴奋性突触后电位评估的双脉冲抑制的降低。2-氨基-5-膦酰基戊酸可阻止NMDA的抑制作用。在30微摩尔的甲溴东莨菪碱存在下,所有这些相互作用仍然可见。α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)和海人酸均未对腺苷反应产生抑制作用。NMDA的存在并未改变巴氯芬对群体电位或双脉冲抑制的作用。通过诱导长时程增强或用甘氨酸灌流激活NMDA受体,也显著降低了腺苷对群体峰电位和双脉冲相互作用的影响。通过一种不涉及NMDA受体激活的机制(增加刺激强度)增加群体电位大小,并未改变对腺苷的敏感性。当测试腺苷受体选择性激动剂时,发现NMDA并未改变腺苷A(1)受体激动剂N(6)-环戊基腺苷的抑制作用,但增强了腺苷A(2A)受体激动剂2-[对-(2-羧乙基)苯乙氨基]-5'-N-乙基甲酰胺基腺苷(CGS21680)的兴奋作用。腺苷A(2A)受体选择性拮抗剂4-(2-[7-氨基-2-(2-呋喃基)[1,2,4]三唑并[2,3a][1,3,5]三嗪-5-基氨基]乙基)苯酚(ZM241385)可阻止对NMDA和CGS21680的联合反应。得出的结论是,NMDA受体激活可通过作用于突触前位点抑制神经元对腺苷的敏感性,并且这种相互作用是由腺苷A(2A)受体兴奋作用的增加引起的,而不是A(1)受体功能的抑制。